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Abstract
The study of animal models of heritable cerebrovascular diseases can improve our understanding of disease mechanisms,
identify candidate genes for related human disorders, and provide experimental models for preclinical trials. Here we
describe a spontaneous mouse mutation that results in reproducible, adult-onset, progressive, focal ischemia in the brain.
The pathology is not the result of hemorrhage, embolism, or an anatomical abnormality in the cerebral vasculature. The
mutation maps as a single site recessive locus to mouse Chromosome 9 at 105 Mb, a region of shared synteny with human
chromosome 3q22. The genetic interval, defined by recombination mapping, contains seven protein-coding genes and one
processed transcript, none of which are changed in their expression level, splicing, or sequence in affected mice. Targeted
resequencing of the entire interval did not reveal any provocative changes; thus, the causative molecular lesion has not
been identified.
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Introduction
Hereditary vascular and cerebrovascular diseases such as
Hereditary Hemorrhagic Telangiectasia (HHT), Cerebral Cav-
ernous Malformation (CCM), and Cerebral Autosomal Dominant
Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
(CADASIL) are clinically significant in their own right and also
provide insights into the molecular mechanisms underlying blood
vessel formation and integrity. Through the identification of such
mutations, the roles of TGF-beta signaling (HHT) [1,2,3,4],
integrin pathways (CCM) [5,6,7,8,9], and Notch signaling
(CADASIL)[10,11] have been clearly demonstrated to be central
to vascular biology. The brain is often the affected organ in such
diseases. This sensitivity may reflect the complete dependence of
the nervous system on aerobic respiration and also the complex
relationship between the endothelial cells, pericytes, astrocytes and
neurons comprising the neurovascular unit.
Animal models of such hereditary vascular diseases are needed
for mechanistic studies and are also of interest in stroke research as
a model of vascular impairment without the confound of surgical
intervention. Therefore, the identification of new animal models of
heritable vascular diseases is important for research, and for
identifying candidate disease genes for related human conditions.
We have identified a spontaneous mutation in mice that leads to
adult onset, bilateral, progressive cerebral ischemia. We have
termed these mice ‘‘Decrepit’’ or dcr for their unhealthy appearance
and shortened lifespan. The affected mice do not show evidence of
clotting (embolism), hemorrhage (aneurism), or anatomical abnor-
malities in the cerebral vasculature. The mutation is inherited as a
single recessive locus on mouse Chromosome 9, between 104.684
and 105.457 Mb, an interval containing seven genes and one
processed transcript. These genes, and the region of shared synteny
in the human genome, are therefore candidates for human
hereditary vascular diseases.
Methods
Animal studies
All studies were performed in accordance with the Guide for the
Care and Use of Laboratory Animals, and all procedures were
approved by The Jackson Laboratory Animal Care and Use
Committee, comprehensive protocol #01026, approval date Nov.
29, 2007. Strains, ages, and the number of animals examined in
given experiments are provided in the text and figure legends at
appropriate points. Animals were provide food (NIH 6% diet) and
water ad libitum and were kept on a standard 14-10 light-dark
cycle.
Histology and immunocytochemistry
Standard histological staining techniques were used to analyze
the pathology of the dcr mice. Tissue was fixed in Bouin’s fixative,
and was dehydrated and paraffin embedded using an automated
tissue processor in the Histology and Light Microscopy Service at
The Jackson Laboratory. Four mm paraffin sections were then cut
using a microtome and collected onto slides for staining. Standard
hematoxylin and eosin staining, phosphotungstic acid hematoxy-
lin, and hemosiderin staining protocols were used. Sections stained
for anti-glial fibrilary acidic protein (GFAP) were processed
equivalently, but stained with a rabbit polyclonal antibody against
GFAP (Sigma, St. Louis, MO, USA) and an HRP-conjugated anti-
rabbit secondary antibody (Vector Labs, Burlingame, CA, USA).
The signal was developed with diaminobenzidine (DAB) and
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Micro-CT imaging
Mice were anesthetized and perfused transcardially with yellow
Microfil resin (Flow Tech, Inc., Carver, MA, USA), a radio-
opaque silicone rubber containing particulate lead chromate and
lead sulfate, and known for minimal shrinkage [12]. The resin was
allowed to set and the entire mouse was fixed by immersion in 4%
buffered formalin. The brain was subsequently dissected free of the
skull and embedded in low melting point agarose. Micro-CT
images were acquired in a 2 hour protocol in which 720 views
were obtained through 360u rotation with a GE eXplore Locus SP
Specimen Scanner using peak voltage 80 kVp, current 80 A [13].
The micro-CT images were reconstructed with isotropic cubic
voxels of size 20 mm.
Confocal imaging
Confocal reconstructions of the penetrating vessels and
capillaries of the brain were obtained by breeding the dcr mutation
to transgenic mice expressing GFP driven by the Tie2 (Tek)
promoter (The Jackson Laboratory strain number JR3658), which
is specifically expressed in blood vessels and myeloid hemopoietic
cells [14]. These mice were then anesthetized and fixed by
perfusion with 4% buffered paraformaldehyde. The brain was
then dissected free and cut into 1 mm coronal sections using a
matrix slicer and Teflon coated razor blade. Sections were
immersed in PBS and imaged using a Leica SP2 confocal
microscope with a 20X objective lens. Serial Z-sections were
collected in 1 mm steps from the surface of the section to a depth of
50 mm. Projections of the Z-stacks are shown. Images were
collected from the cortex near the infarcted regions. At least 4
stacks were collected for each mouse. Five dcr and four littermate
control mice were examined. Mutant mice ranged from 72 to 103
days of age.
Genetic mapping
Themutantdecrepit(dcr)phenotypewasfirstidentified aswasting
and early death in some but not all mice in the double congenic
stock B6-H60
c Cd45
sjl produced by crossing B6.CBy-H60a
c/2Dcr
to B6.SJL-Ptprc
a Pepc
b/BoyJ. dcr was then transferred onto and bred
homozygously on a pure C57BL/6J genetic background. Mapping
was carried out using an F2 cross of (BALB/cByJ x B6-dcr/dcr)a n da
backcross of ((NOD x B6-dcr/dcr) xB6-dcr/dcr)) mice. For finer
mapping, B6-dcr/dcr mice were bred to B6 background BALB
congenics originally derived from B10.C-H7
b/(47N)Sn (strain
JR430) which spanned the decrepit candidate interval, then tested
for reduced BALB congenic segments that correlated with either
retention of a healthy phenotype or conversion to the decrepit
phenotype. All Mb positions are based on NCBI build 37, as
accessed viatheUCSC In-SilicoPCRwebsite (http://genome.ucsc.
edu/cgi-bin/hgPcr?org=Mouse&db=mm8&hgsid=92079956).
All genotyping was by simple sequence length polymorphism
(SSLP). Initial localization to Chr. 9 was based on a genome-
wide scan for linkage using Mit markers. For finer mapping, a
series of D9Dcr primers (the most informative primers are listed
below, additional markers in the interval can be found on the
Mouse Genome Informatics website - www.informatics.jax.org/)
were designed using Ensembl sequence such that primer pairs
spanned regions of dinucleotide repeats. All primers were
designed with 60 degree Centrigrade annealing temperatures,
with products of ,100 bp. About 40% of primer pairs produced
in this way included usable B6 vs. BALB polymorphisms.
D9Dcr56F: TTTAAGACTTTATTCATGTGTCTCCAAAA
D9Dcr56R: GAAGCATCACATAAAACGTGTGTGT
(104.684 Mb, equivalent of D9Mit53)
D9Dcr70F: ACGAGTGGGCCAGTGAGTTCT
D9Dcr70R: CACTCATGGCTGTAAGCTTCGTA
(105.262 Mb)
D9Dcr75F: GCTGGCTATAAATACCTACATTAAGAGTGT
D9Dcr75R: TGCATAGTTAGAGATGACCTTGAACA
(105.382 Mb)
D9Dcr76F: AAAGACTGAGTGTGTGGAGTTGATCT
D9Dcr76R: TTACAGACTTCCCTTCCTTACATTAACA
(105.457 Mb)
Candidate gene analysis
Genes were examined for their expression level, splicing and
sequence. RNA from the brain of affected (approximately three
month old) dcr mice was prepared using Trizol reagent (Invitrogen,
Carlsbad, CA, USA). Total RNA (5 mg) was then used for reverse
transcription using a mix of oligo-dT and random hexamer
primers and Superscript III reverse transcriptase (Invitrogen,
Carlsbad, CA, USA). This first-strand cDNA was used for Syber
Green QPCR (Qiagen, Valencia, CA, USA) analysis on an
ABI7900 (Applied Biosystems, Calsbad, CA, USA). Alternatively
the cDNA was used as a template for amplification of coding
sequences and sequencing of the PCR products. The RNA was
also subject to poly-A+ selection (20 mg of oligo-dT per 500 mgo f
total RNA, Ambion, Austin, TX, USA) and northern blotting
using PCR amplified probes for each gene in the dcr interval.
Northern blotting was done by standard procedures using
randomly primed alpha-dCT
32P labeled probes. Signals were
detected and quantified using both a phosphoimager (Fujifilm,
Tokyo, Japan) and film (Kodak, Rochester, NY, USA). Blots were
run in triplicate and at least three mutant and three control
samples were on each blot.
Array capture and targeted resequencing
Genomic DNA was prepared from the spleen of an affected dcr
male mouse using phenol chloroform extraction and isopropanol
precipitation. The DNA was then sent to Nimblegen for array
capture (Nimblegen, Madison, WI, USA). A microarray with
385,000 features was created containing 60 bp tiled synthetic
oligos spanning the 772 kb dcr genetic interval. The array was
designed and printed by Nimblegen and repeat sequences were
masked, leaving 654,907 bases of the interval on the array. The
genomic DNA was then fragmented, hybridized to the array, and
eluted. The eluted sample was prepared for Illumina sequencing
by the Vanderbilt University Microarray Shared Resource. From
the sequencing, a total of 7,434,305 reads were obtained (36 bp
non-paired end), of which 3,419,255 mapped to the Chr. 9 interval
using MAQ software (downloadable at http://sourceforge.net/
projects/maq/files/), confirming excellent enrichment from the
array capture. Only 1227 base pairs had read depths less than 3,
and only 425 bases included on the array were not sequenced at
least once. Computational analysis for single nucleotide polymor-
phisms (SNPs) using MAQ software detected four putative SNPs.
All of these were shown to be errors in the reference genome when
PCR amplified and resequenced by Sanger methods.
Results
Overt phenotype of dcr homozygous mice
Mice with the decrepit phenotype are normal at birth and for
the first two months of life. At approximately 10 weeks of age, the
mice begin to look unkempt, with a scruffy coat and abnormally
hunched posture. Once affected, the mice are behaviorally
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stimulation and then lethargic (after approximately 15 weeks of
age). The mice cease to gain weight and begin wasting after
approximately 12 weeks of age (Figure 1A). Most mice succumb to
the condition between 18 and 22 weeks of age, a survival curve for
11 males is shown in Figure 1B. Male and female mice are equally
affected.
Histopathology of dcr homozygous mice
Full necropsies of five overtly affected, late-stage dcr mice were
performed in consultation with a veterinary pathologist at The
Jackson Laboratory. No pathology was seen in any organ system
except the brain. In the brain, completely vacuolated regions were
seen in the ventral cortex (Figure 2A). These regions were
contiguous with the pial surface of the brain and were bilaterally
symmetric. Consistent with an infarct, the vacuolated area was
bounded by normal tissue (Figure 2A, B). Other brain regions
were also affected, including the ventral hippocampus (not shown)
and the perisagital dorsal cortex (Figure 2C). Severely dilated
blood vessels were frequently observed, although such structures
may also represent fixation artifacts (Figure 2D). Regions of the
brain that did not show obvious pathology with standard
histological stains did show signs of stress; for example, GFAP-
positive reactive astrocytes were observed in the striatum
(Figure 2E). This reaction in apparently normal brain regions
may represent a response to degenerating axonal projections from
other affected brain regions, or may be presaging eventual
degeneration in other brain regions.
Despite pathology consistent with an infarct, we were unable to
find evidence of typical stroke mechanisms such as hemorrhage or
emboli. These were sought by serial sectioning through areas of
recent damage, determined by the presence of dying neurons with
eosin-rich cytoplasm and pyknotic nuclei, followed by phospho-
tungstic acid hemotoxylin (PTAH) and hemosiderin staining. In
such areas, no PTAH-positive clots or hemosiderin-positive
evidence of hemorrhage were found. Furthermore the bilateral
symmetry of the damage makes such a mechanism less likely.
Degeneration is progressive
In evaluating the onset and time course of the decrepit
phenotype, it is clear that the disease is progressive (Figure 3A–
E). In a systematic evaluation, zero of five mice in their tenth week
of age showed pathology in the ventral cortex. Four out of five
mice in the twelfth week of age showed an eosin-pale, sharply
bounded region of apparent ischemia in the cortex. Dying
neurons, denoted by their eosin-positive soma and condensed
nuclei, were still present in this region suggesting a recent tissue
insult (Figure 3F). By the fourteenth week of age, all mice were
identifiable by histology (5 of 5), and the afflicted regions were
larger and mostly devoid of neurons. By the 16th week, additional
brain areas such as the inferior hippocampus were also affected.
By the eighteenth week of age, four of four mice examined had
large regions of completely vacuolated tissue in the inferior cortex
and hippocampus. The dorsal cortex more rostrally was also
affected by this age, although it was not affected in any of the five
mice examined at sixteen weeks of age (Figure 3H, I). The affected
regions of the brain were always roughly bilateral, and the pattern
and severity were not markedly different in the different
hemispheres.
Cerebrovascular anatomy
The anatomy of the cerebral vasculature in the decrepit mice
was examined using a variety of methods. First, we used micro-CT
reconstruction to examine the brain vasculature at a resolution of
20 microns. Mice were anesthetized and perfused systemically
through the left ventricle with 4% buffered formalin followed by
Microfil, a radio-opaque latex resin. The brain was then dissected
free from of the skull and embedded in agarose for imaging.
Reconstruction of the vessels did not reveal any major anatomical
abnormalities (Figure 4A–C). The middle and anterior cerebral
arteries supply the regions of the brain that are affected, and the
areas are close to watershed zones of perfusion. However, the
pathology (complete vacuolization of the tissue) is most consistent
with ischemia and not a hypoperfusion and resulting hypoxia,
which should instead result in a glial scar. Furthermore, other
organs sensitive to low blood flow, such as the renal papillus, were
unaffected (not shown, n=5). Interestingly, after the mice were
moderately affected (approximately 100 days of age or greater),
they became difficult to perfuse with fixative or resin. This change
was not restricted to the brain, organs such as the kidneys and liver
also filled poorly. If perfusion with resins was performed without
prior fixation, the vessels appeared fragile and the resins
permeated the tissue rather than simply filling the vasculature;
however, tracers such as Evan’s Blue did not leak from the
Figure 1. Growth and Mortality curves of dcr homozygous mice. A) The body weights of 20 control C57BL/6J male mice and 6 C57BL/6J dcr/
dcr male mice are shown (mean 6 SD). The body weights of the affected males begin to significantly diverge from controls at about 12 weeks of age.
Gradual wasting is seen as the mice age. B) The survival of 11 C57BL/6J dcr/dcr mice is shown. Mice begin dying at 3 months of age. By 6 months, all
eleven affected mice were dead. Control C57BL/6J mice from the same colony show no mortality in the same period. Note the number of mice in the
body weight graph decreases with time due to mortality; however, at 12 weeks of age when the mutant curve diverges, all mice were alive.
doi:10.1371/journal.pone.0015327.g001
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these qualitative differences in the ability to perfuse the
vasculature, we suspect that vessels throughout the body are
affected by the dcr mutation, although dysfunction resulting in
ischemia and tissue death is restricted to the nervous system.
Smaller penetrating blood vessels and capillaries in the cortical
regions bordering the infarcts were visualized by breeding a Tie2-
GFP transgene that expresses GFP specifically in endothelial cells
into the decrepit background. Coronal brain slices were then
imaged using a confocal microscope to produce 50 mm recon-
Figure 2. Pathology in the brain of dcr mice. A) A coronal section of a dcr mouse indicates bilaterally symmetric loss of neurons in the lateral,
inferior cerebral cortex (arrowheads). B) The tissue loss is consistent with a regional ischemia resulting in complete vacuolization of the tissue in the
affected region with normal surrounding tissue. C) Other regions of the brain such as the dorsal medial cortex eventually become affected. D) Dilated
blood vessels are often present in the brains of affected mice. E) Activated astrocytes in the striatum stained for GFAP indicate stress reactions in
regions of the brain that do not show obvious pathology (Arrowheads). Note that E is from additional sectioning of the same sample in a region
comparable to D.
doi:10.1371/journal.pone.0015327.g002
Figure 3. The pathology of the dcr locus is progressive. A time course was performed examining five mice at each of five time points from 10
to 18 weeks (only four study mice survived to 18 weeks). A) At ten weeks, none of the mice showed obvious pathology in the inferior lateral cortex. B)
By twelve weeks, four out of five mice showed detectable pathology in the inferior lateral cortex. Eosin pale areas and dying neurons (between the
arrowheads, see also F) in the cortex were evident and were present in both hemispheres. C) By fourteen weeks of age, all mice showed marked
pathology in the cortex with vacuolization of the tissue. D) At sixteen weeks of age, the affected regions were larger and included not only the cortex,
but also the inferior hippocampus (see also G). E) By eighteen weeks of age, the surviving mice had extreme tissue loss and vacuolization. F) At early
stages (twelve weeks) dying neurons identified by their eosin-positive cell bodies and condensed nuclei (black arrowhead) were evident abutting
regions of apparently healthy neurons (white arrowhead) indicating a recent insult and consistent with the regional damage of an ischemic event.
The image is a higher magnification view of the regions boxed in B, rotated 90 degrees clockwise. G) The hippocampus of sixteen week dcr animals
also shows dying neurons in the CA regions of the hippocampus (CA3 shown) although the dentate gyrus (at right) remains relatively unaffected. H)
The dorsal medial cortex is unaffected at sixteen weeks of age in all five mice examined. I) By eighteen weeks of age, the dorsal cortex is also involved,
and eosin-pale, vacuolated areas are visible. Note H and I are more rostral than other sections, the affected dorsal medial cortical regions were
consistently seen rostrally to the inferior lateral cortical regions (see also figure 2).
doi:10.1371/journal.pone.0015327.g003
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changes in vessels were observed.
Decrepit genetics
The dcr mutation arose spontaneously in a C57BL/6J (B6)-
background strain carrying 2 independent congenic segments and
was then transferred to a homogeneous B6 background. Male and
female mice were equally affected and the phenotype did not
segregate with either congenic segment. To map dcr, an affected
(presumed homozygous) B6 male was bred to BALB/cByJ females
and their F1 progeny were intercrossed to produce an F2
generation that yielded affected offspring at the anticipated
frequency (12/53). This cross indicated that dcr acts as a recessive
allele segregating as a single locus and that the decrepit phenotype
is not substantially affected by genetic background variation. A
low-density genome scan using 103 informative SSLP Mit markers
spanning the mouse autosomes was performed on ten affected
mice and twelve unaffected F2 littermates. Chromosome 9
showed linkage with the mutation, with all ten affected mice
being homozygous for the B6 allele of D9Mit182 (101.431 Mb),
while no unaffected mice were homozygous for B6 at that marker
(Chi square test 1.4e
26). The position was confirmed and limited
to an interval between D9Mit53 and D9Mit116 (104.6 to
108.5 Mb) with additional flanking markers, the analysis of
additional F2 mice, and a mapping backcross using an NOD/LtJ
mapping partner. Higher resolution mapping was performed
using a congenic reduction approach in which dcr was opposed a
BALB/c segment from chromosome 9 congenic B6.C-H7
b/
(47N)SnDcr mice. The analysis of .2000 meioses narrowed the
interval to 772, 552 bp on chromosome 9, between 104684730
and 105457282 bp (D9Mit53/D9Dcr56 and D9Dcr76) (Figure 5).
The marker D9Dcr56 was excluded proximally from the candidate
interval by 3 recombinant mice, 1 from F2 crosses and 2 from
decreasing the BALB congenic interval. Distally, D9Dcr76 was
excluded from the candidate interval by 3 separate recombinant
mice, all from decreasing the BALB congenic interval. Therefore,
this interval appears to be suppressed for recombination and no
recombinations were recorded in .1000 of the most recent
meioses tested using markers 0.7 Mb apart (D9Dcr56 and
D9Dcr75), Additional mapping of F2 mice was performed using
other strains including 129 (14 meioses), C3H (314 meioses), and
SJL (72 meioses), confirming the interval on Chromosome 9, but
failed to narrow it further. This indicates that the phenotype is
robust on a number of genetic backgrounds, but also suggests that
the reduced recombination rate is not necessarily specific to
B6.BALB/c mice.
Figure 4. Vascular anatomy in dcr mice. A–C) The vasculature of control (A) and two affected dcr (B, C) mice at 100 days of age was reconstructed
using micro-CT imaging. A and B are projections viewed ventrally, C viewed dorsally. The reconstructions presented are projections, but data can be
viewed in three dimensions and rotated to examine anatomy of the vasculature. No marked changes in vascular anatomy were seen in the mutant
animals. D, E) Smaller penetrating vessels and capillaries of the brain were examined in coronal sections using a GFP transgene to label endothelial
cells. D) A projection of a 50 mm vertical confocal reconstruction, the pial surface is in the upper left. E) Confocal analysis of dcr mice did not reveal a
marked change in the small vessels of the brain. The pial surface in E is just out of the field at the top left, the autofluorescence in the lower left is the
necrotic tissue in the cortex.
doi:10.1371/journal.pone.0015327.g004
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transcript, and a novel miRNA (Figure 5 and Table 1). None of
the genes are obvious candidates for a vascular disease; but
conversely, none can be ruled out. The region of the mouse
genome shares synteny with human chromosome 3q22.1, which
contains the same genes in the same relative orientations. In
addition, several non-coding RNAs including a U6 splicosomal
RNA are annotated in the human genome.
The protein coding candidate genes were examined by QPCR
and northern blotting to look for differences in expression level or
splicing; however, no changes were detected. The genes have also
been sequenced from cDNA generated by reverse transcription of
brain mRNA isolated from affected dcr mice. All genes amplified
and no changes in sequence from the C57BL/6 reference
sequence were detected. The entire 772 kb genomic interval was
resequenced by array capture and high-throughput sequencing
(see methods) with an average sequencing depth of 151 fold. Four
SNPs were detected in comparison to the reference genome. All
were confirmed but also found to be present in unaffected C57BL/
6J mice. Thus, these SNPs are genuine variations from the
reference sequence, but are not pathological. While coverage was
not complete because repeat sequences were masked out of the
array capture, only 425 bases included on the capture array were
not sequenced, all of these were adjacent to masked repeat
Figure 5. The dcr interval. The dcr locus maps between marker D9Dcr56 and D9Dcr76. The spacing megabase positions of these markers and two
other markers within the interval are shown. Examples of genotypes defining the proximal (D9Dcr56) and distal (D9Dcr76) ends of the region are
shown. Mice homozygous for C57BL/6 markers in the region are affected (dcr/dcr homozygotes) whereas mice heterozygous or homozygous for
BALB/c markers through the region are unaffected. Both ends of the interval are confirmed by at least three independent recombination events. The
position of the protein coding genes within the interval is shown below. Gene symbols are at the proximal end of the features. The noncoding miRNA
(AC117688.1) and the processed transcript (AC1130161) are also shown.
doi:10.1371/journal.pone.0015327.g005
Table 1. Genes in the dcr genetic interval.
Gene symbol strand Location Gene name
Cpne4 For 9:104449616-
104936874
Copine 4
AC117688.1 For 9:104897246-
104827349
Novel miRNA
Mrpl3 For 9:104955569-
104979796
Mitochondrial ribosomal protein L3
Nudt16 Rev 9:105031668-
105034135
Nudix (Nucleotide diphosphate linked moiety
X-type motif) 16
1700080E11Rik Rev 9:105045674-
105047412
Unannotated, same protein family as Nudt16
Nek11 Rev 9:105064797-
105297854
NIMA (Never in mitosis gene A) related
expressed kinase 11
AC1130161 For 9:105235843-
105250710
Novel processes transcript
Aste1 For 9:105297722-
105308088
Asteroid homolog 1 (transcription factor)
Atp2c1 Rev 9:105313693-
105433477
ATPase, Ca
2+ sequestering
The gene symbol, coding strand, base positions, and full gene names are given.
doi:10.1371/journal.pone.0015327.t001
Heritable Cerebral Ischemia in Mice
PLoS ONE | www.plosone.org 6 December 2010 | Volume 5 | Issue 12 | e15327sequence and none were in exons. This sequence has been
uploaded to the NCBI Sequence Reads Archive (http://www.
ncbi.nlm.nih.gov/Traces/sra/sra.cgi?) and is available for further
analysis (Accession # in process).
Discussion
The dcr mutation appears to represent a heritable model of
vascular disease, with particularly severe pathology in the brain.
However, both the disease mechanism and the underlying genetic
defect remain mysterious. The bilaterally-symmetric, gradually-
progressive nature of the disease argues against a mechanism such as
emboli or ruptured aneurisms, and no histological evidence for these
mechanismswasfound.Anatomicalabnormalitiescould leadtosuch
a reproducible and localized disease, but no obvious abnormalities
were seen using either micro-CT reconstruction of larger vessels or
confocal analysis of smaller penetrating vessels or capillaries. A
functional defect such as vasospasm could also lead to the observed
pattern of degeneration. We have not explored this mechanism
extensively, but the administration of vasodilators in the drinking
water between 60 and 90 days of age did not markedly alter the
course of the disease. Anatomical defects such as vascular shunts
could also account for such localized pathology, and could also have
been challenging to detect by our methods. The presence of dilated
vessels could reflect veins subjected to arterial pressures, and such
shunts could result in insufficient tissue perfusion. Thus, our results
are consistent with neurodegeneration arising from cerebral
ischemia, but the reasons for this ischemia and for the anatomical
specificity of the degeneration will require additional study.
The genetic mechanism of the dcr mutation is equally puzzling.
The phenotype is fully penetrant, and the heritability is completely
consistent with a single recessive locus mapping to Chr. 9 at
105 Mb. However, analysis of the expression level, splicing, and
coding sequence of the known genes in the interval did not reveal
any provocative changes. The QPCR analysis performed
encompassed a larger interval, including forty genes from Cpne4
extending distally to 2.4 Mb to Dock3. An apparent expression
difference in Ccg1b was explained by a polymorphism in the
primer sequence, and this gene was subsequently excluded from
the genetic interval by recombination. No other changes in
expression were observed, decreasing the likelihood of a mutation
in non-coding regulatory element affecting the expression of a
gene at a distance. No known tRNAs are found in the 0.77 Mb
interval, and targeted resequencing of the entire interval should
have detected any polymorphisms or deletions in the region, even
in non-coding sequences.
Other chromosomal aberrations, such as inversions or copy
number variations, may have been missed by the resequencing
(which was aligned to the reference genome, but not assembled de
novo). The detection of SNPs is quite straightforward, as
demonstrated by the identification of four changes in comparison
to the reference genome. Similarly, a deletion should have been
detected as an absence of coverage relative to the reference. The
insertion of novel DNA sequences, such as a retrovirus, may have
been missed because such sequences would be categorized as
failing to map to the interval. Similarly, inversions would also be
difficult to detect with our methods and a small aberration within
the interval may also account for the reduced recombination
frequency observed, although inversion breakpoints may have
been noted as areas of reduced sequencing coverage because the
rearranged DNA would again be categorized as not mapping to
the reference genome. Changes in copy number (duplications or
expansions, since no deletions were detected) could also be difficult
to detect, but no obvious changes in the depth of sequencing
coverage were observed. To be deleterious, changes such as
inversions, insertions or copy number variations would be
anticipated to change gene expression levels, and no changes in
mRNA levels were detected. Additional analysis such as paired
end sequencing with increased read length or QPCR with multiple
amplicons distributed across each gene may reveal changes that
have been missed in our analysis thus far. However, at present, the
underlying genetic anomaly of the dcr mice also remains to be
determined.
As techniques for identifying rare disease loci in small patient
populations improve, it is increasingly likely that a related human
vascular disease will map to human Chr. 3q22, the region of
shared synteny with the mouse dcr region. In the human genome,
querying the Online Mendelian Inheritance in Man (OMIM)
database did not reveal any analogous diseases mapping to the
region of 3q22.
Our purpose in reporting the dcr locus is to make other
investigators aware that an animal model of such a disease exists,
which could be used to validate patient genetic mapping and any
subsequent genetic lesion identified in the human genome. If a
stronger linkage to human disease is determined to exist, further
study of this animal model to determine the cause and to develop
effective treatments may be warranted. Despite extensive charac-
terization, robust Mendelian inheritance, and full penetrance,
both the physiological basis and the genetic basis for the cerebral
pathology are yet to be determined.
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